Cargando…

Long-term outcome of thyroid abnormalities in patients with severe Covid-19

OBJECTIVE: We have previously observed thyroid dysfunction, i.e. atypical thyroiditis (painless thyrotoxicosis associated with non-thyroidal illness syndrome), in patients with severe acute respiratory syndrome coronavirus 2 disease (Covid-19). This study aimed to analyse the evolution of thyroid dy...

Descripción completa

Detalles Bibliográficos
Autores principales: Muller, Ilaria, Daturi, Anita, Varallo, Matteo, Re, Tiziana E, Dazzi, Davide, Maioli, Sara, Crivicich, Erica, Di Marco, Francesco, Longari, Virgilio, Dazzi, Beatrice, Castellani, Massimo, Mantovani, Giovanna, Arosio, Maura, Salvi, Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083670/
https://www.ncbi.nlm.nih.gov/pubmed/36715690
http://dx.doi.org/10.1530/ETJ-22-0200
_version_ 1785021577736224768
author Muller, Ilaria
Daturi, Anita
Varallo, Matteo
Re, Tiziana E
Dazzi, Davide
Maioli, Sara
Crivicich, Erica
Di Marco, Francesco
Longari, Virgilio
Dazzi, Beatrice
Castellani, Massimo
Mantovani, Giovanna
Arosio, Maura
Salvi, Mario
author_facet Muller, Ilaria
Daturi, Anita
Varallo, Matteo
Re, Tiziana E
Dazzi, Davide
Maioli, Sara
Crivicich, Erica
Di Marco, Francesco
Longari, Virgilio
Dazzi, Beatrice
Castellani, Massimo
Mantovani, Giovanna
Arosio, Maura
Salvi, Mario
author_sort Muller, Ilaria
collection PubMed
description OBJECTIVE: We have previously observed thyroid dysfunction, i.e. atypical thyroiditis (painless thyrotoxicosis associated with non-thyroidal illness syndrome), in patients with severe acute respiratory syndrome coronavirus 2 disease (Covid-19). This study aimed to analyse the evolution of thyroid dysfunction over time. METHODS: One hundred eighty-three consecutive patients hospitalised for severe Covid-19 without known thyroid history were studied at hospital admission (baseline). Survivors were offered 12-month longitudinal follow-up including assessment of thyroid function, autoantibodies and ultrasound scan (US). Patients showing US focal hypoechoic areas suggestive of thyroiditis (focal hypoechogenicity) also underwent thyroid (99m)Tc or (123)I uptake scan. RESULTS: At baseline, after excluding from TSH analysis, 63 out of 183 (34%) Covid-19 patients commenced on steroids before hospitalisation, and 12 (10%) showed atypical thyroiditis. Follow-up of 75 patients showed normalisation of thyroid function and inflammatory markers and no increased prevalence of detectable thyroid autoantibodies. Baseline US (available in 65 patients) showed focal hypoechogenicity in 28% of patients, of whom 82% had reduced thyroid (99m)Tc/(123)I uptake. The presence of focal hypoechogenicity was associated with baseline low TSH (P = 0.034), high free-thyroxine (FT4) (P = 0.018) and high interleukin-6 (IL6) (P = 0.016). Focal hypoechogenicity persisted after 6 and 12 months in 87% and 50% patients, respectively, but reduced in size. After 9 months, thyroid (99m)Tc/(123)I uptake partially recovered from baseline (+28%) but was still reduced in 67% patients. CONCLUSIONS: Severe Covid-19 induces mild transient thyroid dysfunction correlating with disease severity. Focal hypoechogenicity, associated with baseline high FT4, IL6 and low TSH, does not seem to be related to thyroid autoimmunity and may persist after 1 year although decreasing in size. Long-term consequences seem unlikely.
format Online
Article
Text
id pubmed-10083670
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Bioscientifica Ltd
record_format MEDLINE/PubMed
spelling pubmed-100836702023-04-11 Long-term outcome of thyroid abnormalities in patients with severe Covid-19 Muller, Ilaria Daturi, Anita Varallo, Matteo Re, Tiziana E Dazzi, Davide Maioli, Sara Crivicich, Erica Di Marco, Francesco Longari, Virgilio Dazzi, Beatrice Castellani, Massimo Mantovani, Giovanna Arosio, Maura Salvi, Mario Eur Thyroid J Research OBJECTIVE: We have previously observed thyroid dysfunction, i.e. atypical thyroiditis (painless thyrotoxicosis associated with non-thyroidal illness syndrome), in patients with severe acute respiratory syndrome coronavirus 2 disease (Covid-19). This study aimed to analyse the evolution of thyroid dysfunction over time. METHODS: One hundred eighty-three consecutive patients hospitalised for severe Covid-19 without known thyroid history were studied at hospital admission (baseline). Survivors were offered 12-month longitudinal follow-up including assessment of thyroid function, autoantibodies and ultrasound scan (US). Patients showing US focal hypoechoic areas suggestive of thyroiditis (focal hypoechogenicity) also underwent thyroid (99m)Tc or (123)I uptake scan. RESULTS: At baseline, after excluding from TSH analysis, 63 out of 183 (34%) Covid-19 patients commenced on steroids before hospitalisation, and 12 (10%) showed atypical thyroiditis. Follow-up of 75 patients showed normalisation of thyroid function and inflammatory markers and no increased prevalence of detectable thyroid autoantibodies. Baseline US (available in 65 patients) showed focal hypoechogenicity in 28% of patients, of whom 82% had reduced thyroid (99m)Tc/(123)I uptake. The presence of focal hypoechogenicity was associated with baseline low TSH (P = 0.034), high free-thyroxine (FT4) (P = 0.018) and high interleukin-6 (IL6) (P = 0.016). Focal hypoechogenicity persisted after 6 and 12 months in 87% and 50% patients, respectively, but reduced in size. After 9 months, thyroid (99m)Tc/(123)I uptake partially recovered from baseline (+28%) but was still reduced in 67% patients. CONCLUSIONS: Severe Covid-19 induces mild transient thyroid dysfunction correlating with disease severity. Focal hypoechogenicity, associated with baseline high FT4, IL6 and low TSH, does not seem to be related to thyroid autoimmunity and may persist after 1 year although decreasing in size. Long-term consequences seem unlikely. Bioscientifica Ltd 2023-01-30 /pmc/articles/PMC10083670/ /pubmed/36715690 http://dx.doi.org/10.1530/ETJ-22-0200 Text en © the author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Research
Muller, Ilaria
Daturi, Anita
Varallo, Matteo
Re, Tiziana E
Dazzi, Davide
Maioli, Sara
Crivicich, Erica
Di Marco, Francesco
Longari, Virgilio
Dazzi, Beatrice
Castellani, Massimo
Mantovani, Giovanna
Arosio, Maura
Salvi, Mario
Long-term outcome of thyroid abnormalities in patients with severe Covid-19
title Long-term outcome of thyroid abnormalities in patients with severe Covid-19
title_full Long-term outcome of thyroid abnormalities in patients with severe Covid-19
title_fullStr Long-term outcome of thyroid abnormalities in patients with severe Covid-19
title_full_unstemmed Long-term outcome of thyroid abnormalities in patients with severe Covid-19
title_short Long-term outcome of thyroid abnormalities in patients with severe Covid-19
title_sort long-term outcome of thyroid abnormalities in patients with severe covid-19
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083670/
https://www.ncbi.nlm.nih.gov/pubmed/36715690
http://dx.doi.org/10.1530/ETJ-22-0200
work_keys_str_mv AT mullerilaria longtermoutcomeofthyroidabnormalitiesinpatientswithseverecovid19
AT daturianita longtermoutcomeofthyroidabnormalitiesinpatientswithseverecovid19
AT varallomatteo longtermoutcomeofthyroidabnormalitiesinpatientswithseverecovid19
AT retizianae longtermoutcomeofthyroidabnormalitiesinpatientswithseverecovid19
AT dazzidavide longtermoutcomeofthyroidabnormalitiesinpatientswithseverecovid19
AT maiolisara longtermoutcomeofthyroidabnormalitiesinpatientswithseverecovid19
AT crivicicherica longtermoutcomeofthyroidabnormalitiesinpatientswithseverecovid19
AT dimarcofrancesco longtermoutcomeofthyroidabnormalitiesinpatientswithseverecovid19
AT longarivirgilio longtermoutcomeofthyroidabnormalitiesinpatientswithseverecovid19
AT dazzibeatrice longtermoutcomeofthyroidabnormalitiesinpatientswithseverecovid19
AT castellanimassimo longtermoutcomeofthyroidabnormalitiesinpatientswithseverecovid19
AT mantovanigiovanna longtermoutcomeofthyroidabnormalitiesinpatientswithseverecovid19
AT arosiomaura longtermoutcomeofthyroidabnormalitiesinpatientswithseverecovid19
AT salvimario longtermoutcomeofthyroidabnormalitiesinpatientswithseverecovid19